Waters reports sales of $431 million for first quarter 2014

Waters Corporation (NYSE/WAT) reported today first quarter 2014 sales of $431 million, essentially flat versus sales of $430 million in the first quarter of 2013. In the quarter, the effect of foreign currency translation was neutral to sales growth. On a GAAP basis, earnings per diluted share (E.P.S.) for the first quarter of 2014 were $0.82 compared to $1.39 for the first quarter of 2013. On a non-GAAP basis, E.P.S. were down 14% to $0.92 compared to $1.07 in the prior year quarter.

Commenting on the quarter, Douglas A. Berthiaume, Chairman, President, and Chief Executive Officer, said, "Sales in the quarter were below our expectations due primarily to a combination of slower growth in Asia and delays in the release of capital budgets, most significantly in the United States. Foreign currency translation and a higher operating tax rate negatively affected E.P.S in comparison to the 2013 first quarter's results."


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
A step forward in vaccine technology: Exploring the effects of N1-methylpseudouridine in mRNA translation